![[PDF]](/pb-assets/Icons/adobe-pdf-icon-1498649896243.png){kind=icon}
Abstract
There are currently over 170 synthetic cannabinoids monitored by the European Union Early Warning System, making it the single largest group of new psychoactive substances, often marketed as “legal” replacements to cannabis. The Internet, coupled with cheap and efficient shipping, has allowed countries like China and India to become the chemical and pharmaceutical wholesalers and retailers to the world. These companies ship synthetic cannabinoids to Europe, where they are processed and packaged into a range of products, smokable herbal mixtures being the most common one. The herbal mixtures, often referred to as “Spice,” are then sold via online shops on the surface web, using sophisticated marketing techniques, potentially generating high profits. We decided to use available data on the synthetic cannabinoid 5F-MDMB-PINACA to estimate those profits. After making an inventory of the required materials and the typical retail price, we made a lower and upper bound profit estimation. We found that the return on costs varies between 3.3 and 24.4 after the first production and rises to a range between 5.5 and 42.5. By applying a basic economic model, our estimations show that profits in this type of business are substantial.
References
|
Archer, J., Hudson, S., Abouchedid, R., Ho, J., Wood, D., Dargan, P. (2017, 5). Synthetic cannabinoid receptor agonist (SCRA) detection from pooled urine samples in central London. Paper presented at the 37th Congress of the European Association of Poison Centres and Clinical Toxicologists, Basel, Switzerland. Google Scholar | |
|
Auwärter, V., Dresen, S., Weinmann, W., Müller, M., Pütz, M., Ferreirós, N. (2008). Spice and other herbal blends: Harmless incense or cannabinoid designer drugs? Journal of Mass Spectrometry, 44, 832–837. Google Scholar | Crossref | |
|
Becker, G. S. (1968). Crime and Punishment: An economic approach. Journal of Political Economy, 76, 169–217. Google Scholar | Crossref | ISI | |
|
Bretteville-Jensen, A. L., Tuv, S. S., Bilgrei, O. R., Fjeld, B., Bachs, L. (2013). Synthetic cannabinoids and cathinones: Prevalence and markets. Forensic Science Review, 25, 7–26. Google Scholar | Medline | |
|
Brunt, T. M., Atkinson, A. M., Nefau, T., Martinez, M., Lahaie, E., Malzcewski, A.…Brandt, S. D . (2017). Online test purchased new psychoactive substances in 5 different European countries: A snapshot study of chemical composition and price. International Journal of Drug Policy, 44, 105–114. Google Scholar | Crossref | Medline | |
|
Cellini, S. R., Kee, J. E. (2010). Cost-effectiveness and cost-benefit analysis. In Wholey, J. S., Hatry, H. P., Newcomer, K. E. (Eds.). Handbook of practical program evaluation (pp. 493–530). San Francisco, CA: Jossey-Bass. Google Scholar | |
|
Chatwin, C., Measham, F., Sumnall, H. (2017). New drugs, new directions? Research priorities for new psychoactive substances and human enhancement drugs. International Journal of Drug Policy, 40, 1–5. Google Scholar | Crossref | Medline | |
|
Curtis, B., Alanis-Hirsch, K., Kaynak, O., McLellan, A. T., Meyers, K. (2015). Using web searches to track interest in synthetic cannabinoids (aka “herbal incense”). Drug and Alcohol Review, 34, 105–108. Google Scholar | Crossref | Medline | |
|
Easton, S. T. (2004). Marijuana growth in British Columbia (Public Policy Sources 74). Vancouver, BC: The Fraser Institute. Google Scholar | |
|
European Commission—TAXUD . (2017). VAT Rates applied in the EU Member States. Situation at 1st January 2017. Brussels, Belgium: European Commission. Google Scholar | |
|
European Monitoring Centre for Drugs and Drug Addiction . (2017). European drug report 2017: Trends and developments. Luxembourg: Publications Office of the European Union. Google Scholar | |
|
European Monitoring Centre for Drugs and Drug Addiction & European School Survey Project on Alcohol and Other Drugs . (2016). ESPAD Report 2015. Results from the European School Survey Project on Alcohol and Other Drugs. Luxembourg: Publications Office of the European Union. Google Scholar | |
|
European Monitoring Centre for Drugs and Drug Addiction and Eurojust . (2016). New psychoactive substances in Europe: Legislation and prosecution—current challenges and solutions. Luxembourg: EMCDDA–Eurojust joint publication, Publications Office of the European Union. Google Scholar | |
|
European Monitoring Centre for Drugs & Drug Addiction & Europol . (2016). EU drug markets report: In-depth analysis. Luxembourg: EMCDDA-Europol Joint Publications, Publications Office of the European Union. Google Scholar | |
|
European Monitoring Centre for Drugs and Drug Addiction & Europol . (2017). Joint Report on a new psychoactive substance: Methyl 2-{[1-(5-fluoropentyl)-1H-indazole-3-carbonyl]amino}-3,3-dimethylbutanoate (5F-MDMB-PINACA; 5F-ADB). Luxembourg: EMCDDA and Europol Joint Reports, Publications Office of the European Union. Google Scholar | |
|
Evans-Brown, M., Sedefov, R. (2017). New psychoactive substances: Driving greater complexity into the drug problem. Addiction, 112, 36–38. Google Scholar | Crossref | Medline | |
|
Hammersley, R. (2010). Letters to the Editor: Dangers of banning spice and the synthetic cannabinoid agonists. Addiction, 105, 373–375. Google Scholar | Crossref | Medline | |
|
Hughes, B., Winstock, A. (2012). Controlling new drugs under marketing regulations. Addiction, 107, 1894–1899. Google Scholar | Crossref | Medline | ISI | |
|
Langer, N., Lindigkeit, R., Schiebel, H.-M., Papke, U., Ernst, L., Beuerle, T. (2016). Identification and quantification of synthetic cannabinoids in ‘spice-like’ herbal mixtures: Update of the German situation for the spring of 2016. Forensic Science International, 269, 31–41. Google Scholar | Crossref | Medline | |
|
Masum, H., Tovey, M. (2012). The reputation society: How online opinions are reshaping the offline world. Cambridge, MA: MIT Press. Google Scholar | |
|
Moosmann, B., Franz, F, Angerer, V, Auwärter, V. (2017). Technical review on [2-(1-(5-fluoropentyl)- 1H-indazole-3-carboxamido)-3,3-dimethylbutanoate] 5F-MDMB-PINACA. Lisbon: EMCDDA, Unpublished EMCDDA contract, ref. CT.16.SAT.0101.1.0. Google Scholar | |
|
O’Brien, K., Chatwin, C., Jenkins, C., Measham, F. (2015). New psychoactive substances and British drug policy: A view from the cyber-psychonauts. Drugs: Education, Prevention, and Policy, 22, 217–223. Google Scholar | Crossref | |
|
Piggee, C. (2009). Investigating a not-so-natural high. Analytical Chemistry, 81, 3205–3207. Google Scholar | Crossref | Medline | ISI | |
|
Pirona, A., Bo, A., Hedrich, D., Ferri, M., van Gelder, N., Giraudon, I.…Mounteney, J . (2017). New psychoactive substances: Current health-related practices and challenges in responding to use and harms in Europe. International Journal of Drug Policy, 40, 84–92. Google Scholar | Crossref | Medline | |
|
Rachlin, R. (1997). Return on investments manual: Tools and applications for managing financial results. New York, NY: M. E. Sharpe Inc. Google Scholar | |
|
Schäffer, M., Gröger, T., Pütz, M., Zimmermann, R. (2013). Assessment of the presence of damiana in herbal blends of forensic interest based on comprehensive two-dimensional gas chromatography. Forensic Toxicology, 31, 251–262. Google Scholar | Crossref | |
|
Schäper, J. (2016). Wirkstoffgehalte und inhomogene Verteilung des Wirkstoffs MDMB-CHMICA in Kräutermischungen’. Toxichem Krimtech, 83, 112–114. Google Scholar | |
|
Seddon, T. (2014). Drug policy and global regulatory capitalism: The case of new psychoactive substances (NPS). International Journal of Drug Policy, 25, 1019–1024. Google Scholar | Crossref | Medline | |
|
Sumnall, H., Evans-Brown, M., McVeigh, J. (2011). Social, policy, and public health perspectives on new psychoactive substances. Drug Testing and Analysis, 3, 515–523. Google Scholar | Crossref | Medline | |
|
The Guardian . (2017, 15 4). ‘It’s worse than heroin’: How spice is ravaging homeless communities. Retrieved from https://www.theguardian.com/society/2017/apr/15/its-worse-than-heroin-how-spice-is-ravaging-homeless-communities Google Scholar | |
|
Vanhove, W., Surmont, T., Van Damme, P., De Ruyver, B. (2014). Filling in the blanks. An estimation of illicit cannabis growers’ profits in Belgium. International Journal of Drug Policy, 25, 436–443. Google Scholar | Crossref | Medline | |
|
VolteFace . (2016). High hopes. Retrieved from http://volteface.me/features/high-hopes-psychoactive-substances-act/ Google Scholar | |
|
Wadsworth, E., Drummond, C., Deluca, P. (2017). The adherence to UK legislation by online shops selling new psychoactive substances. Drugs: Education, Prevention and Policy, 1–4. Google Scholar |
